 pany's annual report for 2024. Further information on remuneration to senior executives is available in 
note 12 (Number of employees, salaries, other remuneration and social security expenses) on pages 53-54 in 
the annual report 2024 . Information on the work of the Remuneration Committee in 2024 is set out in the 
corporate governance report available on page 91 in the annual report 2024 . 
Remuneration of the board of directors is not covered by this report. Such remuneration is resolved annually 
by the annual general meeting and disclosed in note 12 on pages 53-54 in the annual report 2024 . During 2024 , 
the chairman of the board of directors Jørgen Drejer and the board member s Pierandrea Muglia and John 
Haurum have received remuneration for consultancy services corresponding to MSEK 0.2, MSEK 1.2 and MSEK 
0.1, respectively. 
Key developments during 2024 
The CEO summarizes the company’s overall performance in his statement on page 5 in the annual report 2024 . 
The company’ 2024 . 
The company’s remuneration guidelines: scope, purpose and deviations 
A prerequisite for the successful implementation of the company’s business strategy and safeguarding of the 
company’s long -term interests, including its sustainability, is that the company is able to recruit and retain highly 
competent senior executives wi th a capacity to achieve set goals. In order to achieve this, the company must 
offer a competitive total remuneration on market terms. The company’s remuneration guidelines enable the 
company to offer executives a competitive total remuneration on market t erms. Under the remuneration 
guidelines, remuneration to senior executives may consist of the following components: fixed salary, variable 
cash remuneration, pension benefits and other benefits. The variable cash remuneration shall be linked to 
financial o r non -financial criteria. They may be individualized quantitative or qualitative objectives. The criteria 
shall be designed to contribute to  ive programs. 
Table 1 – Total remuneration of the CEO in 2024 (kSEK) 
Name of director 
(position) 1 
Fixed remuneration 2 
Variable remuneration 3 4 5 6 
Base salary1) Other 
benefits2) One-year 
variable Multi -year 
variable3) Extraordinary 
items4) Pension 
expense5) Total 
remuneration Proportion of 
fixed and 
variable 
remuneration 
Thomas Feldthus 
(CEO) 2,423 36 0 951 617 242 4,269 63/37 
1) No holiday pay paid. 
2) This column includes the value of benefits and perquisites such as social security expenses and other benefits in kind or per quisites. 
3) Vested employee options as set out in column 1 1 of Table 2(a) below. 
4) During 2024, the board of directors resolved to grant an extraordinary one -time bonus of kSEK 617 to CEO Thomas Feldthus . 
5) Pension expense (column 4), which in its entirety is based on Base salary. 
 
Share -based remuneration 
Ended share -related and share price -related incentive programs during 202 4 
On 19 January 2018, an extraordinary general f kSEK 617 to CEO Thomas Feldthus in acknowledgment of his outstanding 
performance in relation to the negotiation and closing of the significant partnership with Acadia 
Pharmaceuticals in November 2024.

4 
 
 Comparative information on the change of remuneration and company performance 
Table 4 – Change of remuneration and company performance over the last five reported financial years (RFY) 
(kSEK) * 
 RFY 2024 RFY 2023 RFY 2022 RFY 2021 RFY 2020 
CEO remuneration 4,269 
(+24% ) 3,430 
(-77%) 14,8721) 
(+102%) 7,360 
(+1%) 7,2552) 
Deputy CEO remuneration 03) 
(0%) 03) 
(-100%) 1,031 
(-64%) 2,894 
(+19%) 2,4264) 
Group operating profit 241,885 
(+398%) -81,065 
(+64%) -225,3735) 
(+45%) -411,570 
(-158%) -159,375 
Average remuneration on a full -time equivalent basis 
of employees of the Saniona Group6) 1,173 
(+17%) 1,003 
(-32%) 1,483 
(-17%) 1,786 
(+39%) 1,282 
* Including t he percentage change from the previous year in brackets. 
1) Including remuneration for CEO Thomas Feld